These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 19545378)

  • 1. Neurofibromatosis type 2 (NF2): a clinical and molecular review.
    Evans DG
    Orphanet J Rare Dis; 2009 Jun; 4():16. PubMed ID: 19545378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II].
    Evans DG
    Genet Med; 2009 Sep; 11(9):599-610. PubMed ID: 19652604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 2.
    Evans GR; Lloyd SKW; Ramsden RT
    Adv Otorhinolaryngol; 2011; 70():91-98. PubMed ID: 21358190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis type 2 (NF2): diagnosis and management.
    Lloyd SK; Evans DG
    Handb Clin Neurol; 2013; 115():957-67. PubMed ID: 23931824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
    Ruggieri M; Praticò AD; Evans DG
    Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.
    Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG
    Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 2.
    Evans DG
    Handb Clin Neurol; 2015; 132():87-96. PubMed ID: 26564072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?
    Leverkus M; Kluwe L; Röll EM; Becker G; Bröcker EB; Mautner VF; Hamm H
    Br J Dermatol; 2003 Apr; 148(4):804-9. PubMed ID: 12752143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
    Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
    J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 2.
    Evans DG; Sainio M; Baser ME
    J Med Genet; 2000 Dec; 37(12):897-904. PubMed ID: 11106352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further genotype--phenotype correlations in neurofibromatosis 2.
    Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
    Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
    Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
    J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients.
    Hexter A; Jones A; Joe H; Heap L; Smith MJ; Wallace AJ; Halliday D; Parry A; Taylor A; Raymond L; Shaw A; Afridi S; Obholzer R; Axon P; King AT; ; Friedman JM; Evans DG
    J Med Genet; 2015 Oct; 52(10):699-705. PubMed ID: 26275417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
    Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of multiple tumors in neurofibromatosis type 2 patients.
    Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP
    Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.
    Kehrer-Sawatzki H; Kluwe L; Friedrich RE; Summerer A; Schäfer E; Wahlländer U; Matthies C; Gugel I; Farschtschi S; Hagel C; Cooper DN; Mautner VF
    Hum Genet; 2018 Jul; 137(6-7):543-552. PubMed ID: 30006736
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.